Processing...
Processing...
Inmagic
®
Presto
Version 5.5 Build 151
Inmagic
®
Presto
Copyright © 2005-2021 by Lucidea Technologies Corp., Richmond BC Canada. All rights reserved.
Inmagic® and the Inmagic logo are registered trademarks of Lucidea Technologies Corp.
Unauthorized duplication or distribution is prohibited.
Other brand and product names are trademarks or registered trademarks of their respective holders. Use of any other product name does not imply endorsement of that product by Inmagic.
Third-party Licenses
Processing...
Processing...
Title
Antidepresivos tricíclicos para los trastornos del espectro autista (TEA) en niños y adolescentes
Author
Romy Hurwitz; Roger Blackmore; Philip Hazell; Katrina Williams; Susan Woolfenden
Summary
This online article, written in Spanish, summarizes a research review conducted to determine whether tricyclic antidepressants (TCAs) can be used to treat autism symptoms, as well as challenging behaviors and co-occurring mental health conditions in autism.
Cochrane is a “global independent network of researchers, professionals, patients, carers, and people interested in health.” [Website] The network reviews evidence about health treatments.
Language
Spanish
Subjects
Mental Health
Publisher
Cochrane
DateModified
12/30/2022 7:36 PM EST